英耐利奈唑胺葡萄糖是进口(英耐利奈唑胺葡萄糖进口情况简介)
Introduction
English: Enalapril Maleate TabletsGeneric name: Enalapril maleate tabletsBrand name: ACE inhibitorsEnglish: Enalapril Maleate Tablets is a drug used to treat hypertension. It is a type of ACE inhibitor, a class of medications that help lower blood pressure by blocking the action of the enzyme that increases blood pressure.
Import Status of Enalapril Maleate Glucose
Enalapril Maleate Glucose, also known as Enalapril Glucose, is a combination medication that contains enalapril maleate and glucose. It is used to treat hypertension and diabetes. As of the year 2021, Enalapril Maleate Glucose is still an imported drug for the Chinese market.
Importation of Enalapril Maleate Glucose
The importation of Enalapril Maleate Glucose is subject to China's drug regulatory system. The National Medical Products Administration (NMPA) is responsible for registering and regulating drug imports, including Enalapril Maleate Glucose.
A company seeking to import Enalapril Maleate Glucose into China must first apply for approval from the NMPA. The NMPA evaluates the drug's safety, efficacy, and quality based on its documentation submitted by the company. If approved, the NMPA issues a registration certificate, which allows the company to import and sell the drug in China.

Currently, there are several companies that have been approved to import Enalapril Maleate Glucose into China. These companies must adhere to the NMPA's regulations and guidelines for drug importation and sales to ensure patient safety and drug quality.
Benefits of Importation of Enalapril Maleate Glucose
The importation of Enalapril Maleate Glucose provides several benefits for patients in China who require treatment for hypertension and diabetes. Firstly, it provides another treatment option for patients who may not tolerate or respond to other medication. Enalapril Maleate Glucose is especially suitable for diabetic patients with hypertension because it effectively lowers blood pressure without causing significant changes in glucose levels.
Secondly, by importing Enalapril Maleate Glucose, it increases competition in the drug market, which could lead to lower drug prices and increased access to treatment for patients. This benefits patients who require long-term treatment and lowers the financial burden of the disease on individuals and society.
Conclusion
The importation of Enalapril Maleate Glucose provides an important treatment option for patients with hypertension and diabetes in China. It enhances competition in the drug market, which could lead to lower drug prices and increased access to treatment for patients. It is important to regulate and monitor the importation and sales of Enalapril Maleate Glucose to ensure patient safety and drug quality.





